Professional Biography
Michelle Ovanesian is an associate in the Litigation Department and a member of the Firm’s Intellectual Property Group and Life Sciences Patent practice.
More Legal and Business Bylines From Michelle M. Ovanesian
Alleged Theft of Drug Pricing Trade Secrets Could Cost Both Victim and Thief (Posted On Tuesday, November 28, 2023) FTC Continues to Stake Out Role as Key AI Regulator (Posted On Tuesday, September 26, 2023) Recent Partial Dismissal of Illinois Biometric Privacy Suit May Add Some Weight to the Scale on the Side of Defendants (Posted On Tuesday, September 05, 2023) SolarWinds: A Lesson on How Companies Victimized by Data Breaches Can Quickly Become the Target of Litigation and Regulatory Investigations (Posted On Wednesday, November 16, 2022) When Nondisclosure Agreements and Pharmaceutical Trade Secrets Intersect (Posted On Wednesday, December 15, 2021) President Biden’s Executive Order on Competition Signals Potential Changes Affecting Patents in the Healthcare Sector (Posted On Wednesday, July 28, 2021) Bioplastics: Snickers® Candy Bars Have It Wrapped Up (Posted On Wednesday, April 21, 2021) COVID-19 “Not a Golden Ticket” to Avoid Discovery Obligations (Posted On Monday, February 01, 2021) COVID-19 and Immunity from Liability (Posted On Wednesday, January 27, 2021) Are Antitrust Claims Against Licensors of Standard Essential Patents Dead On Arrival? (Posted On Tuesday, October 20, 2020)
gtag('event','author_read', {
'organization','Proskauer Rose LLP'
});
